Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation
Related Experiment Video
Updated: Jul 3, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
1Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
Abstract:
Our previous studies have demonstrated the involvement of HIF-1 and p53 in the regulation of stanniocalcin-1 (STC1) gene transcription in human cancer cells. In this study, we reported that the treatment of human colon adenoma HT29 cells with a histone deacetylase (HDAC) inhibitor (i.e. trichostatin A, TSA) induced both cellular apoptosis and STC1 expression. The activation of STC1 expression was also observed in other TSA-treated human cancer cells (i.e. SKOV3, CaCo-2, Jurkat and CNE-2 cells). STC1 mRNA was rapidly induced within 4 h in TSA-treated HT29 cells, and was found to be transcriptionally regulated and was independent of new protein synthesis as revealed by ActD and CHX treatment respectively. The induction was correlated with increased cellular levels of acetyl histone H3 and H4 and acetyl NFkappaB. Chromatin immunoprecipitation (ChIP) assay showed the increased binding of acetyl histone H3 and H4 to STC1 promoter in the TSA-treated cells. A cotreatment of HT29 cells with a NFkappaB inhibitor (parthenolide) significantly inhibited the TSA-induced cellular levels of acetyl NFkappaB p65 and abolished the stimulation of STC1 gene expression. ChIP assay also demonstrated that TSA treatment increased while TSA/parthenolide cotreatment decreased NFkappaB p65 binding to STC1 gene promoter. In the STC1-luciferase promoter construct (1 kb) study, the data implied that the promoter can be activated by TSA treatment. Interestingly, the promoter region contains 2 putative NFkappaB binding sites. Consistent with the STC1mRNA expression data, TSA/parthenolide cotreatment also significantly inhibited the TSA-induced STC1 promoter-driven luciferase activity. Importantly, TSA-induced apoptotic process was found to be significantly reduced by the silencing of STC1 expression. This is the first study to show that histone hyper-acetylation and the recruitment of activated NFkappaB stimulated STC1 gene expression. In addition, our results support the notion that STC1 is a pro-apoptotic factor.
Insights
Histone deacetylase inhibitor trichostatin A (TSA) induces stanniocalcin-1 (STC1) expression and apoptosis in cancer cells. This occurs via histone hyper-acetylation and NF-kappaB activation, with STC1 promoting apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Previous studies implicated HIF-1 and p53 in stanniocalcin-1 (STC1) gene transcription regulation in human cancer cells.
- Histone deacetylase (HDAC) inhibitors are known to affect cellular processes, including apoptosis and gene expression.
Purpose of the Study:
- To investigate the effect of HDAC inhibition on STC1 expression and apoptosis in human cancer cells.
- To elucidate the molecular mechanisms underlying TSA-induced STC1 gene expression and its role in apoptosis.
Main Methods:
- Treatment of human colon adenoma HT29 cells and other cancer cell lines (SKOV3, CaCo-2, Jurkat, CNE-2) with trichostatin A (TSA).
- Analysis of STC1 mRNA and protein levels, cellular apoptosis, histone acetylation, and NF-kappaB activation.
- Chromatin immunoprecipitation (ChIP) assays, reporter gene assays, and gene silencing experiments.
Main Results:
- TSA treatment induced cellular apoptosis and STC1 expression across multiple human cancer cell lines.
- STC1 induction was rapid, transcriptionally regulated, and correlated with increased histone H3/H4 acetylation and NF-kappaB activation.
- NF-kappaB activation was crucial for TSA-induced STC1 expression, and STC1 silencing reduced TSA-induced apoptosis.
Conclusions:
- Histone hyper-acetylation and NF-kappaB recruitment stimulate STC1 gene expression in response to HDAC inhibition.
- STC1 acts as a pro-apoptotic factor, mediating the apoptotic effects of TSA in cancer cells.
- This study reveals a novel epigenetic mechanism regulating STC1 and highlights its role in cancer cell death.
More Related Videos
13:53Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells
Published on: August 26, 2021
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
The JAK-STAT Signaling Pathway